-
Impact of a Structured Patient Education Module on Knowledge of Botulinum Toxin Therapy, Goal Attainment, and Treatment Satisfaction in Cervical Dystonia
-
Impact of Alpha-Synuclein Burden and Cellular Stress on GBA-PD Macrophage
-
Impact of Amyloid-beta co-pathology on future hallucination in Parkinson’s disease
-
Impact of Caffeine Consumption on Clinical Phenotype and Non-Motor Symptoms in Parkinson’s Disease
-
Impact of Comorbidities on Clinical Outcomes and Socioeconomic Burden in Parkinson’s Disease: A 10-Year Nationwide Cohort Study
-
Impact of Continuous Subcutaneous Foslevodopa/Foscarbidopa (FLC/FCD) on Non-Motor Symptom Burden in Advanced Parkinson’s Disease: Domain-Level Analysis
-
Impact of Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion on Neuropsychiatric Symptoms in Clinical Practice: A Multicenter Study
-
Impact of foslevodopa/foscarbidopa infusion on autonomic symptoms in advanced Parkinson’s Disease
-
Impact of Helicobacter pylori Eradication on MDS-UPDRS Part III Motor Score in Patients With Parkinson’s Disease A Prospective Cohort Study in Northern Mexico
-
Impact of Hula on Balance Outcomes in Parkinson’s Disease
- « Previous Page
- 1
- …
- 100
- 101
- 102
- 103
- 104
- …
- 208
- Next Page »
